Summary

Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered (Upper Body, Lower Body and Full Body), Mode of Operation (Powered, Passive and Hybrid), Form of Exoskeleton (Rigid and Soft), Mobility (Fixed / Supported and Mobile), End Users (Patients and Healthcare Providers), and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World)
Report Link: https://www.rootsanalysis.com/reports/medical-exoskeleton-market.html
The Medical Exoskeleton Market is expected to reach USD 10.9 billion anticipated to grow at a CAGR of 20.8% during the forecast period 2024-2035.

Medical exoskeletons, wearable robotic devices designed to assist individuals with mobility impairments, integrate mechanical, electronic, and computer-controlled systems to enhance movement. Targeting specific affected body parts, they differ from traditional assistive tools like wheelchairs and crutches. Some powered exoskeleton variants offer active mobility support by boosting user strength and endurance through actuators and sensors. The potential of medical exoskeletons is significant, addressing a large patient demographic in need of mobility aid. Neurological disorders, such as traumatic brain injury (TBI) and spinal cord injury, affect millions globally.

Despite the substantial need for mobility assistance, the exoskeleton market remains niche, largely due to high costs and limited awareness among patients and healthcare providers. However, ongoing technological advancements and increased awareness signal potential market expansion. Several companies are pioneering exoskeleton technology with advanced features like controllers and software applications, empowering users and clinicians to tailor rehabilitation plans to individual needs. This innovation holds promise for enhancing accessibility and quality of life for those requiring mobility support.


Research Coverage:
This chapter offers an insightful overview of the exoskeleton industry, delving into the origins of exoskeleton technology. It provides detailed information on the classification of exoskeletons, including their various applications, features, and associated limitations. Additionally, the chapter explores the future perspectives of exoskeleton technology, offering a discussion on potential advancements and emerging trends in this field.
This overview offers comprehensive insights into the current market landscape of medical exoskeletons, taking into account various crucial parameters. These include the development status, covering both commercialized and under development products, along with body part coverage, encompassing upper extremity, lower extremity, and full-body exoskeletons. The analysis also extends to the mode of operation, distinguishing between powered, passive, and hybrid exoskeletons, as well as the form of exoskeletons, which can be rigid or soft exosuits. Additionally, the analysis considers end users, including patients, medical professionals, and researchers, as well as patient age groups, ranging from pediatric to adolescent and adolescent to elderly demographics. It further explores various exoskeleton settings, including home/community and rehabilitation centers. The overview also touches upon breakthrough device designations, exoskeleton technology/software, maximum weight, weight carrying capacity, and dimensions. Furthermore, it provides a list of companies involved in medical exoskeleton development and commercialization, detailing establishment year, company size, headquarters location, ownership, and additional services offered. Lastly, it highlights the most active companies in terms of medical exoskeleton offerings.
An in-depth analysis of product competitiveness in the medical exoskeleton market is provided, centering on several key aspects. Supplier strength is evaluated based on factors such as years of experience, company size, and the breadth of the exoskeleton portfolio. Product competitiveness encompasses various elements, including device mobility, exoskeleton form, operation mode, advanced features, user-machine interface, additional services offered, breakthrough designation, and development status. Furthermore, the analysis considers the target end users of these medical exoskeletons, examining how well-suited the products are for patients, medical professionals, and other potential users. By examining these factors comprehensively, this analysis provides a holistic understanding of the competitive landscape within the medical exoskeleton market.
Thorough profiles are presented for leading medical exoskeleton companies, chosen for their extensive and varied lineup of wearable exoskeletons. Each profile offers a concise overview of the company, detailing its establishment year, employee count, headquarters location, and key leadership team members. Where relevant, insights into financial performance are provided. Additionally, the profiles include information on the company's product range, recent advancements, and an informed perspective on future prospects. By examining these profiles, readers gain valuable insights into the capabilities, offerings, and potential trajectories of prominent players in the medical exoskeleton industry.
Tabulated summaries are presented for top medical exoskeleton companies, chosen for their extensive product offerings and diverse application ranges of wearable exoskeletons. Each tabulated profile offers a concise overview of the company, detailing its establishment year, employee count, headquarters location, and key leadership team members. Additionally, the profiles include information on the company's product portfolio, providing readers with a clear and organized understanding of the capabilities and offerings of each company in the medical exoskeleton market.
An exhaustive analysis is conducted on recent partnerships and collaborations within the medical exoskeleton market since 2017. This analysis examines multiple parameters, including the year of partnership, partnership type (such as mergers and acquisitions, product development and commercialization agreements, licensing agreements, service agreements, product development and manufacturing agreements, joint ventures, manufacturing and supply agreements, and product distribution agreements), partner type (industry and non-industry), trends in business globalization, and identification of the most active players. Additionally, insights are provided into the regional distribution of companies engaged in these agreements, offering a comprehensive understanding of the dynamics shaping collaborations within the medical exoskeleton market in recent years.
A detailed analysis is conducted on patents filed or granted for exoskeletons since 2016, covering various pertinent factors. These include patent type, application and publication years, geographical origins of patents, applicant types, publication timelines, top CPC symbols, and key players with respect to the number of patents filed or granted. Moreover, the analysis includes an in-depth patent benchmarking analysis, offering valuable insights into the patent landscape of exoskeleton technology and highlighting notable trends, developments, and key players within the industry.
A comprehensive analysis is conducted on the current and future medical exoskeleton market, utilizing the principles of the Blue Ocean Strategy. This examination offers a strategic roadmap tailored for emerging medical exoskeleton enterprises to explore uncontested market opportunities. The guide encompasses thirteen strategic tools designed to facilitate a transition towards a Blue Ocean strategy, enabling companies to establish a competitive advantage in the market.
A thorough analysis is conducted on the factors shaping the growth of the medical exoskeleton market. This examination entails identifying and evaluating key drivers, potential limitations, emerging opportunities, and existing obstacles impacting market expansion.
Key Benefits of Buying this Report
The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
The report provides stakeholders with a pulse on the Medical Exoskeleton Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.
Leading Market Companies
Bionic Yantra
CYBERDYNE
Ekso Bionics
ExoAtlet
Fourier Intelligence
Gloreha
Guangzhou Yikang Medical Equipment
Hexar Humancare
Hocoma
MediTouch
Milebot Robotics
Myomo
Neofect
NextStep Robotics
Panasonic
ReWalk Robotics
Rex Bionics
Roam Robotics
Trexo Robotics
Tyromotion
U&O Technologies

ページTOPに戻る

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations

2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates

3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry

3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk

3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION
5.1. Chapter Overview
5.2. Overview of Exoskeleton
5.3. History of Exoskeleton
5.4. Classification of Exoskeleton
5.4.1. Based on Body Part Supported
5.4.2. Based on Form of Exoskeleton
5.4.3. Based on Mode of Operation
5.4.4 Based on Mobility

5.5. Applications of Exoskeleton
5.6. Features of Exoskeleton
5.7. Limitations of Exoskeleton
5.8. Future Perspectives

6. MEDICAL EXOSKELETON: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Medical Exoskeleton: Overall Market Landscape
6.2.1. Analysis by Status of Development
6.2.2. Analysis by Type of Body Part Covered
6.2.3. Analysis by Mode of Operation
6.2.4. Analysis by Type of Body Part Covered and Mode of Operation
6.2.5. Analysis by Form of Exoskeleton
6.2.6. Analysis by Mode of Operation and Form of Exoskeleton
6.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
6.2.8. Analysis by Device Mobility
6.2.9. Analysis by Mode of Operation and Device Mobility
6.2.10. Analysis by Form of Exoskeleton and Device Mobility
6.2.11. Analysis by Type of Body Part Covered and Device Mobility
6.2.12. Analysis by User-Machine Interface
6.2.13. Analysis by Type of Body Part Covered and User-Machine Interface
6.2.14. Analysis by Mode of Operation and User-Machine Interface
6.2.15. Analysis by Availability of Advanced Features
6.2.16. Analysis by End User
6.2.17. Analysis by Patient Age Group
6.2.18. Analysis by Exoskeleton Setting for Patients
6.2.19. Analysis by Breakthrough Designation

6.3. Medical Exoskeleton: Developer: Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Analysis by Company Size and Location of Headquarters
6.3.5. Analysis by Company Ownership
6.3.6. Analysis by Location of Headquarters and Company Ownership
6.3.7. Analysis by Additional Services Offered
6.3.8. Most Active Players: Analysis by Number of Medical Exoskeleton

7. MEDICAL EXOSKELETON: PRODUCT COMPETITVENESS ANALYSIS
7.1 Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology

7.4. Medical Exoskeleton: Product Competitiveness Analysis
7.4.1. Product Competitiveness Analysis: Upper Body Medical Exoskeleton
7.4.1.1. Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
7.4.1.2. Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
7.4.1.3. Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton

7.4.2. Product Competitiveness Analysis: Lower Body Exoskeleton
7.4.2.1. Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
7.4.2.2. Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
7.4.2.3. Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton

7.4.3. Product Competitiveness Analysis: Full Body Medical Exoskeleton

8. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES
8.1. Chapter Overview
8.2. CYBERDYNE
8.2.1. Company Overview
8.2.2. Financial Information
8.2.3. Product Portfolio
8.2.4 Recent Developments and Future Outlook

8.3. Ekso Bionics
8.3.1. Company Overview
8.3.2. Financial Information
8.3.3. Product Portfolio
8.3.4 Recent Developments and Future Outlook

8.4. ExoAtlet
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Recent Developments and Future Outlook

8.5. Fourier Intelligence
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Recent Developments and Future Outlook

8.6. Gloreha
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Recent Developments and Future Outlook

8.7. Guangzhou Yikang
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Recent Developments and Future Outlook

8.8. Hexar Humancare
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Recent Developments and Future Outlook

8.9. Hocoma
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Recent Developments and Future Outlook

8.10. Panasonic
8.10.1. Company Overview
8.10.2. Financial Information
8.10.3. Product Portfolio
8.10.4. Recent Developments and Future Outlook

8.11. Tyromotion
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Recent Developments and Future Outlook

9. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES
9.1. Chapter Overview
9.2. Bionic Yantra
9.3. MediTouch
9.4. Milebot Robotics
9.5. Myomo
9.6. Neofect
9.7. NextStep Robotics
9.8. ReWalk Robotics
9.9. Rex Bionics
9.10. Roam Robotics
9.11. Trexo Robotics
9.12. U&O Technologies

10. MEDICAL EXOSKELETON: PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Medical Exoskeleton: List of Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Analysis by Type of Partner
10.3.5. Analysis by Year of Partnership and Type of Partner
10.3.6. Analysis by Purpose of Partnership

10.3.7. Analysis by Geography
10.3.7.1. Local and International Agreements
10.3.7.2. Intracontinental and Intercontinental Agreements
10.3.7.3. Most Active Players: Distribution by Number of Partnerships

11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Exoskeleton: Patent Analysis
11.3.1. Analysis by Patent Application Year
11.3.2. Analysis by Patent Publication Year
11.3.3. Analysis by Type of Patent and Patent Publication Year
11.3.4. Analysis by Publication Time
11.3.5. Analysis by Patent Jurisdiction
11.3.6. Analysis by CPC symbols
11.3.7. Analysis by Type of Applicant
11.3.8. Leading Players: Analysis by Number of Patents
11.3.9. Leading Patent Assignees: Analysis by Number of Patents

11.4. Exoskeleton: Patent Benchmarking
11.4.1. Analysis by Patent Characteristics
11.4.2. Exoskeleton: Patent Valuation

11.5. Leading Players by Number of Citations

12. BLUE OCEAN STRATEGY
12.1. Overview of Blue Ocean Strategy
12.1.1. Red Oceans
12.1.2. Blue Oceans
12.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy

12.1.4. Medical Exoskeleton: Blue Ocean Strategy and Shift Tools
12.1.4.1. Strategy Canvas
12.1.4.2. Pioneer-Migrator-Settler (PMS) Map
12.1.4.3. Buyer Utility Map

13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
13.1. Chapter Overview
13.2. Market Drivers
13.3. Market Restraints
13.4. Market Opportunities
13.5. Market Challenges
13.6. Conclusion

14. MEDICAL EXOSKELETON MARKET
14.1. Chapter Overview
14.2. Forecast Methodology and Key Assumptions
14.3. Medical Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.1. Scenario Analysis

14.4. Key Market Segmentations
14.5. Dynamic Dashboard

15. EXOSKELETON MARKET, BY BODY PART COVERED
15.1. Chapter Overview
15.2. Forecast Methodology and Key Assumptions
15.3. Medical Upper Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.4. Medical Lower Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.5. Medical Full Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.6. Data Triangulation and Validation

16. EXOSKELETON MARKET, BY MODE OF OPERATION
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. Medical Powered Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Medical Passive Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.5. Medical Hybrid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.6. Data Triangulation and Validation

17. EXOSKELETON MARKET, BY THEIR FORM
17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. Medical Rigid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4. Medical Soft Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Data Triangulation and Validation

18. EXOSKELETON MARKET, BY THEIR MOBILITY
18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions
18.3. Medical Fixed/ Supported Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.4. Medical Mobile / Overground Walking Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.5. Data Triangulation and Validation

19. EXOSKELETON MARKET, BY END USERS
19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions
19.3. Medical Exoskeleton by Patients: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.4. Medical Exoskeleton by Healthcare Providers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.5. Data Triangulation and Validation

20. EXOSKELETON MARKET, BY GEOGRAPHY
20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions
20.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.5. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.6. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.7. Data Triangulation and Validation

21. CONCLUSION

22. EXECUTIVE INSIGHTS
22.1. Chapter Overview
22.2. Spain-based Small Company
22.2.1. Company Snapshot
22.2.2. Interview Transcript: Co-Founder and Chief Executive Officer

22.3. Japan-based Small Company
22.3.1. Company Snapshot
22.3.2. Interview Transcript: Director of Business Planning and Development

22.4. US-based Small Company
22.4.1. Company Snapshot
22.4.2. Interview Transcript: Vice President of Sales and Marketing

22.5. Canada-based Small Company
22.5.1. Company Snapshot
22.5.2. Interview Transcript: Marketing and Design Manager

22.6. India-based Small Company
22.6.1. Company Snapshot
22.6.2. Interview Transcript: Founder and Director

23. APPENDIX 1: BLUE OCEAN STRATEGY AND SHIFT TOOLS

24. APPENDIX 2: TABULATED DATA

25. APPENDIX 3: LIST OF COMPANIES AND ORGANIZATION

ページTOPに戻る

List of Tables/Graphs

Figure 2.1 Research Methodology: Research Assumptions
Figure 2.2 Research Methodology: Project Methodology
Figure 2.3 Research Methodology: Forecast Methodology
Figure 2.4 Research Methodology: Robust Quality Control
Figure 2.5 Research Methodology: Key Market Segmentations
Figure 4.1 Executive Summary: Medical Exoskeleton Market Landscape
Figure 4.2 Executive Summary: Partnerships and Collaborations
Figure 4.3 Executive Summary: Patent Analysis
Figure 4.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Types of Mobility Assistive Devices
Figure 5.2 Key Historical Events related to Exoskeleton
Figure 5.3 Classification of Exoskeleton
Figure 5.4 Applications of Exoskeleton
Figure 5.5 Movements Supported by Lower Body, Upper Body and Full Body Exoskeleton
Figure 5.6 Components of a Powered / Robotic Exoskeleton
Figure 5.7 Features of Exoskeleton
Figure 5.8 Limitations of Exoskeleton
Figure 6.1 Medical Exoskeleton: Distribution by Status of Development
Figure 6.2 Medical Exoskeleton: Distribution by Type of Body Part Covered
Figure 6.3 Medical Exoskeleton: Distribution by Mode of Operation
Figure 6.4 Medical Exoskeleton: Distribution Type of Body Part Covered and Mode of Operation
Figure 6.5 Medical Exoskeleton: Distribution by Form of Exoskeleton
Figure 6.6 Medical Exoskeleton: Distribution by Mode of Operation and Form of Exoskeleton
Figure 6.7 Medical Exoskeleton: Distribution Type of Body Part Covered and Form of Exoskeleton
Figure 6.8 Medical Exoskeleton: Distribution by Device Mobility
Figure 6.9 Medical Exoskeleton: Distribution by Mode of Operation and Device Mobility
Figure 6.10 Medical Exoskeleton: Distribution by Form of Exoskeleton and Device Mobility
Figure 6.11 Medical Exoskeleton: Distribution by Type of Body Part Covered and Device Mobility
Figure 6.12 Medical Exoskeleton: Distribution by User-Machine Interface
Figure 6.13 Medical Exoskeleton: Distribution by Type of Body Part Covered and User-Machine Interface
Figure 6.14 Medical Exoskeleton: Distribution by Mode of Operation and User-Machine Interface
Figure 6.15 Medical Exoskeleton: Distribution by Availability of Advanced Features
Figure 6.16 Medical Exoskeleton: Distribution by End User
Figure 6.17 Medical Exoskeleton: Distribution by Patient Age Group
Figure 6.18 Medical Exoskeleton: Distribution by Exoskeleton Setting for Patients
Figure 6.19 Medical Exoskeleton: Distribution by Breakthrough Designation
Figure 6.20 Medical Exoskeleton Companies: Distribution by Year of Establishment
Figure 6.21 Medical Exoskeleton Companies : Distribution by Company Size
Figure 6.22 Medical Exoskeleton Companies : Distribution by Company Size and Employee Count
Figure 6.23 Medical Exoskeleton Companies : Distribution by Location of Headquarters (Region)
Figure 6.24 Medical Exoskeleton Companies : Distribution by Location of Headquarters (Country)
Figure 6.25 Medical Exoskeleton Companies : Distribution by Company Size and Location of Headquarters
Figure 6.26 Medical Exoskeleton Companies : Distribution by Company Ownership
Figure 6.27 Medical Exoskeleton Companies : Distribution by Location of Headquarters and Company Ownership
Figure 6.28 Medical Exoskeleton Companies : Distribution by Additional Services Offered
Figure 6.29 Most Active Players: Distribution by Number of Medical Exoskeleton Location of Headquarters (Country)
Figure 7.1 Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
Figure 7.2 Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
Figure 7.3 Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton
Figure 7.4 Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
Figure 7.5 Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
Figure 7.6 Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton
Figure 7.7 Product Competitiveness Analysis: Full Body Medical Exoskeleton
Figure 8.1 CYBERDYNE: Annual Revenues, FY 2019 – FY 2023 (JPY Billion)
Figure 8.2 CYBERDYNE: Distribution of Revenues by Business Segment, FY 2021- FY 2022
Figure 8.3 Ekso Bionics: Annual Revenues, 2018 – Q1 2023 (USD Billion)
Figure 8.4 Ekso Bionics: Distribution of Revenues by Business Segment, FY 2023
Figure 8.5 Panasonic: Annual Revenues, FY 2018- FY 2023 (JPY Billion)
Figure 10.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 10.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 10.6 Partnerships and Collaborations: Distribution by Purpose of Partnership
Figure 10.7 Partnerships and Collaborations: Local and International Agreements
Figure 10.8 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 10.9 Most Active Players: Distribution by Number of Partnerships
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Pre-2016-2022
Figure 11.3 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, 2016-2022
Figure 11.4 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, 2016-2023
Figure 11.5 Patent Analysis: Distribution by Publication Time
Figure 11.6 Patent Analysis: Distribution by Patent Jurisdiction (Region)
Figure 11.7 Patent Analysis: Distribution by Patent Jurisdiction (Country)
Figure 11.8 Patent Analysis: Distribution by CPC Symbols
Figure 11.9 Patent Analysis: Distribution by Type of Applicant
Figure 11.10 Leading Industry Players: Distribution by Number of Patents
Figure 11.11 Leading Non-Industry Players: Distribution by Number of Patents
Figure 11.12 Leading Individual Assignees: Distribution by Number of Patents
Figure 11.13 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Figure 11.14 Leading Non-Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Figure 11.15 Patent Analysis: Distribution by Patent Age
Figure 11.16 Patent Analysis: Patent Valuation
Figure 12.1 Differences Between Red Ocean Strategy and Blue Ocean Strategy
Figure 12.2 Blue Ocean Strategy: Strategy Canvas
Figure 12.3 Blue Ocean Strategy: Pioneer- Migrator-Settler (PMS) Map
Figure 12.4 Blue Ocean Strategy: Buyer Utility Map
Figure 13.1 Market Drivers
Figure 13.2 Market Restrains
Figure 13.3 Market Opportunities
Figure 13.4 Market Challenges
Figure 14.1 Medical Exoskeleton Market, Historical Trends (2018-2022) and Future Estimates (2023-2035) (USD Million)
Figure 14.2 Medical Exoskeleton Market, Future Estimates (2023-2035), Base Scenario (USD Million)
Figure 14.3 Medical Exoskeleton Market, Future Estimates (2023-2035), Conservative Scenario (USD Million)
Figure 14.4 Medical Exoskeleton Market, Future Estimates (2023-2035), Optimistic Scenario (USD Million)
Figure 15.1 Medical Exoskeleton Market: Distribution by Body Part Covered, 2018, 2023 and 2035 (USD Million)
Figure 15.2 Medical Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 15.3 Medical Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023- 2035)
Figure 15.4 Medical Full Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.1 Medical Exoskeleton Market: Distribution by Mode of Operation, 2018, 2023 and 2035 (USD Million)
Figure 16.2 Medical Powered Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.3 Medical Passive Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.4 Medical Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.1 Medical Exoskeleton Market: Distribution by Form, 2018, 2023 and 2035 (USD Million)
Figure 17.2 Medical Rigid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.3 Medical Soft Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 18.1 Medical Exoskeleton Market: Distribution by Device Mobility, 2018, 2023 and 2035 (USD Million)
Figure 18.2 Medical Fixed / Supported Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 18.3 Medical Mobile / Overground Walking Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 19.1 Medical Exoskeleton Market: Distribution by End Users, 2018, 2023 and 2035 (USD Million)
Figure 19.2 Medical Exoskeleton Market by Patients: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 19.3 Medical Exoskeleton Market by Healthcare Professionals: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.1 Medical Exoskeleton Market: Distribution by Geography, 2018, 2023 and 2035 (USD Million)
Figure 20.2 Medical Exoskeleton Market in North America: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.3 Medical Exoskeleton Market in Europe: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.4 Medical Exoskeleton Market in Asia- Pacific: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.5 Medical Exoskeleton Market in Rest of the World: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 21.4 Concluding Remarks: Overall Medical Exoskeleton Market Landscape
Figure 21.3 Concluding Remarks: Partnerships and Collaborations
Figure 21.4 Concluding Remarks: Patent Analysis
Figure 21.5 Concluding Remarks: Market Forecast and Opportunity Analysis